Last reviewed · How we verify

NCT05503758

Biomechanical Properties of the Lumbar Paravertebral Muscles

Completed Last updated 2 October 2025
What this trial tests

trial testing Myoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia) in Lumbar Paravertebral Muscles in 63 participants. Completed in 29 January 2022.

Timeline
28 June 2021
Primary endpoint
29 January 2022
29 January 2022

Quick facts

Lead sponsorSouth Valley University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment63
Start date28 June 2021
Primary completion29 January 2022
Estimated completion29 January 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

South Valley University

Who can join

Adults 18 to 35, female only, with Lumbar Paravertebral Muscles. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cesarean delivery (CD) is an obstetric surgery for fetal delivery that involves both an abdominal incision (laparotomy) and a uterine incision (hysterotomy). It is presently the most prevalent surgery in the United States, with over 1 million women giving birth by cesarean section each year.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other South Valley University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05503758.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing